TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Jucker Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,552
|
1,462
|
2,898 |
Financial expenses |
686
|
204
|
290 |
Earnings before taxes |
-880
|
53
|
814 |
EBITDA |
-350
|
154
|
1,031 |
Total assets |
6,416
|
4,475
|
4,788 |
Current assets |
6,374
|
4,433
|
4,746 |
Current liabilities |
5,114
|
2,293
|
2,648 |
Equity capital |
1,302
|
2,182
|
2,140 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
2
|
3
|
4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
20.3%
|
48.8%
|
44.7% |
Turnover per employee |
776
|
487
|
724 |
Profit as a percentage of turnover |
-56.7%
|
3.6%
|
28.1% |
Return on assets (ROA) |
-3.0%
|
5.7%
|
23.1% |
Current ratio |
124.6%
|
193.3%
|
179.2% |
Return on equity (ROE) |
-67.6%
|
2.4%
|
38.0% |
Change turnover |
90
|
-1,436
|
-173 |
Change turnover % |
6%
|
-50%
|
-6% |
Chg. No. of employees |
-1
![]() |
-1
|
0 |
Chg. No. of employees % |
-33%
|
-25%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.